Pharmaceutical composition of topiramate

Details Pharmaceutical composition of topiramate Pharmaceutical composition of topiramate

2006-10-24

2006-10-24

Venkat, Jyothsna (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Food or edible as carrier for pharmaceutical

C424S492000

Reexamination Certificate

active

07125560

ABSTRACT:
The invention is directed to a pharmaceutical composition of topiramate, an anticonvulsant which is useful for treating epilepsy. More specifically, the present invention provides a solid dosage formulation of topiramate intended primarily for use by pediatric patients, or for patients who have difficulty swallowing tablets. Processes for preparing the pharmaceutical composition are also described.

REFERENCES:
patent: 4079125 (1978-03-01), Sipos
patent: 4205060 (1980-05-01), Monsimer et al.
patent: 4513006 (1985-04-01), Maryanoff et al.
patent: 4568559 (1986-02-01), Nuwayser et al.
patent: 4639370 (1987-01-01), Carli
patent: 4800087 (1989-01-01), Mehta
patent: 4851226 (1989-07-01), Julian et al.
patent: 4882169 (1989-11-01), Ventouras
patent: 4888177 (1989-12-01), Gergely et al.
patent: 4892740 (1990-01-01), Takasima et al.
patent: 4916161 (1990-04-01), Patell
patent: 4985252 (1991-01-01), Jung et al.
patent: 4994260 (1991-02-01), Kallstrand et al.
patent: 4994496 (1991-02-01), Repasky et al.
patent: 5008117 (1991-04-01), Calanchi et al.
patent: 5013716 (1991-05-01), Cherukuri et al.
patent: 5082669 (1992-01-01), Shirai et al.
patent: 5084278 (1992-01-01), Mehta
patent: 5133974 (1992-07-01), Paradissis et al.
patent: 5147655 (1992-09-01), Ibsen
patent: 5206030 (1993-04-01), Wheatley et al.
patent: 5215755 (1993-06-01), Roche et al.
patent: 5260072 (1993-11-01), Roche et al.
patent: 5275823 (1994-01-01), Frace et al.
patent: 5286489 (1994-02-01), Tsau et al.
patent: 5354566 (1994-10-01), Addesso et al.
patent: 5393333 (1995-02-01), Trouve
patent: 5401502 (1995-03-01), Wunderlich et al.
patent: 5405616 (1995-04-01), Wunderlich et al.
patent: 5409711 (1995-04-01), Mapelli et al.
patent: 5417985 (1995-05-01), Coutel et al.
patent: 5425742 (1995-06-01), Jay
patent: 5460825 (1995-10-01), Roche et al.
patent: 5489436 (1996-02-01), Hoy et al.
patent: RE35200 (1996-04-01), Lehmann et al.
patent: 5560913 (1996-10-01), Kupper et al.
patent: 5578316 (1996-11-01), Bhardwaj et al.
patent: 5607697 (1997-03-01), Alkire et al.
patent: 5633015 (1997-05-01), Gilis et al.
patent: 5641513 (1997-06-01), Lech et al.
patent: 5648096 (1997-07-01), Gander et al.
patent: 5705183 (1998-01-01), Phillips et al.
patent: 5760007 (1998-06-01), Shant et al.
patent: 5795909 (1998-08-01), Shashova et al.
patent: 3012136 (1981-10-01), None
patent: 3943242 (1990-06-01), None
patent: 4201179 (1993-07-01), None
patent: 138441 (1985-04-01), None
patent: 0287 488 (1988-10-01), None
patent: 0350701 (1990-01-01), None
patent: 0446753 (1991-09-01), None
patent: 0317274 (1993-03-01), None
patent: 0459695 (1995-03-01), None
patent: 2025227 (1980-01-01), None
patent: 2153676 (1985-08-01), None
patent: 2153677 (1985-08-01), None
patent: 88/03795 (1988-06-01), None
patent: WO 88/03795 (1999-06-01), None
D.R. Doose et al—50thAnnual meeting of the American Epilepsy society, san Francisco, 1996.
The Physician's desk Reference (52nd Ed., Medical Economics Company) p. 2058.
Taber's Cyclopedia Medical Dictionary (17thEd., F.A Davis Co. ) pp. 532-534.
Janssen—Cilag Farmaceutica, LDA, “Topamax (summary of Product Characteristics of Topiramate, approved by the Portuguese Health Authorities)”, 20 ABR. 2004, Comunica No. 19, p. 11-12.
European Commission, Directorate General III—Industry Pharmaceuticals and Cosmetics, “Guidelines—Medicinal Products for Human Use, Quality and Biotechnology”, The Rules Governing Medicinal Product in European Union, vol. 3A, pp. 143-151, 1998.
European Commission, Directorate General III—Industry Pharmaceuticals and Cosmetics, “Guidelines—Medicinal Products for Human Use, Quality and Biotechnology”, The Rules Governing Medicinal Product in European Union, vol. 3A, pp. 127-141, 1998.
Simposium Terapeutico, Enciclopedia de Especialidades Farmaceuticas Portuguesas “Monography of TOPAMAX”, pp. 1015-1055, 2001.
Simposium Terapeutico, Enciclopedia de Especialidades Farmaceuticas Portuguesas, “Monography of TOPAMAX”, pp. 1015-1017, 2002.
Simposium Terapeutico, Enciclopedia de Especialidades Farmaceuticas Portuguesas, “Monography of TOPAMAX”, pp. 974-977, 2003.
Simposium Terapeutico, Enciclopedia de Especialidades Farmaceuticas Portuguesas, “Monography of TOPAMAX”, pp. 986-989, 2004.

Affiliated with

Also associated with

Rating

Pharmaceutical composition of topiramate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition of topiramate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition of topiramate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3655031